The North America Biopsy Devices Market would witness market growth of 6.4% CAGR during the forecast period (2022-2028).
CT scans and MRIs are used to spot irregular tissue or masses; however, they can’t tell the variance between cancer and non-cancer cells. So, the biopsy is performed to closely inspect collected cells to make a precise cancer diagnosis. Needle biopsy is mainly used for breast lumps and enlarged lymph nodes. When needle biopsy is used with CT scans and MRIs, it can collect cells from a part that is not felt over the skin.
In endoscopy, doctors use a thin endoscope (flexible tube) with a torch to see the inside structure of the body. Special tools are put inside the tube to study the sample tissue to take out the tissue from the infected area. Skin biopsy removes cells from the surface of one’s body. It is used for analysing skin conditions such as melanoma and other cancers.
The kind of skin biopsy one may go through depends on the form of cancer that the doctors and the number of wary cells assume. Bone marrow biopsy is constructed based on blood test outcomes or if the doctors think the tumour is affecting the bone marrow.
According to CDC, in 2019, 1,752,735 new cancer cases were found, while 599,589 people died because of cancer in the United States. 439 new cases of cancer were discovered, while 146 people were found dead from cancer of every 100,000 people. Medical equipment sector of Canada provide opportunities to the investors of United States in the Canadian market. Total imports of medical gadgets satisfies about 70% of local demand.
The US market dominated the North America Biopsy Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $850.3 million by 2028. The Canada market is poised to grow at a CAGR of 8.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 7.9% during (2022 - 2028).
Based on Product, the market is segmented into Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Needles, Biopsy Forceps and Others. Based on Needle-based Biopsy Guns Type, the market is segmented into Vacuum-assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices and Core Needle Biopsy (CNB) Devices. Based on Biopsy Guidance Systems Type, the market is segmented into Manual and Robotic. Based on Biopsy Needles Type, the market is segmented into Disposable and Reusable. Based on End User, the market is segmented into Hospitals, Diagnostic & Imaging Center and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Biopsy Devices Market is Estimated to reach $3 Billion by 2028, at a CAGR of 7.5%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Hologic, Inc., Fujifilm Holdings Corporation, B. Braun Melsungen AG, Danaher Corporation, ConMed Corporation, Becton, Dickinson and Company, Cardinal Health, Inc., Argon Medical Devices, Inc., and Cook Medical, Inc.
By Product
By End User
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 